Skip to main content

Refractory RA patients respond well to peficitinib in phase II study

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Refractory RA patients respond well to peficitinib in phase II study

User login

Username

Password

Reset your password

Type	Lead	score